The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Marseille
E
E
Health Strategies International, Orinda, California 94563, USA. emarseille@home.com
Kahn
J G
JG
Mmiro
F
F
Guay
L
L
Musoke
P
P
Fowler
M G
MG
Jackson
J B
JB
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000517:prevention & control* / Q000635:transmission*; D017954:Africa South of the Sahara; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D005260:Female; D015528:HIV Seroprevalence; D015497:HIV-1; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D015233:Models, Statistical; D009035:Mothers; D019829:Nevirapine / Q000191:economics / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D014454:Uganda
D019380:Anti-HIV Agents; D019829:Nevirapine